0,872  0,004  Caspase 9 stimulant
0,860  0,003  Sensitization
0,756  0,022  Antiinflammatory
0,716  0,009  Antihypercholesterolemic
0,725  0,027  Apoptosis agonist
0,634  0,026  Antineoplastic (lung cancer)
0,586  0,013  Antipruritic, allergic
0,560  0,015  Antineoplastic (pancreatic cancer)
0,561  0,024  Cholesterol antagonist
0,564  0,041  Antineoplastic (breast cancer)
0,525  0,008  UGT1A4 substrate
0,516  0,010  Antineoplastic (endocrine cancer)
0,510  0,006  Anesthetic
0,530  0,039  TNF expression inhibitor
0,504  0,021  Hepatic disorders treatment
0,515  0,033  CYP2C9 substrate
0,491  0,012  UGT2B4 substrate
0,496  0,019  Chemopreventive
0,518  0,042  Transcription factor NF kappa B inhibitor
0,492  0,016  Antipyretic
0,485  0,011  Antihypoxic
0,479  0,009  Anesthetic general
0,484  0,023  Lipoprotein disorders treatment
0,468  0,006  UGT2B7 substrate
0,498  0,040  Antileukemic
0,470  0,015  UGT1A6 substrate
0,457  0,008  Abortion inducer
0,453  0,008  Prostate disorders treatment
0,449  0,005  Antipruritic, non-allergic
0,469  0,033  CYP2C19 inhibitor
0,455  0,020  Nitric oxide antagonist
0,461  0,026  NOS3 expression inhibitor
0,445  0,012  Calcium channel activator
0,441  0,009  Interferon gamma antagonist
0,456  0,025  UGT1A9 substrate
0,472  0,046  CYP3A4 substrate
0,436  0,010  Prostatic (benign) hyperplasia treatment
0,425  0,004  ABCA1 expression enhancer
0,455  0,039  Vasodilator, peripheral
0,425  0,010  UGT1A3 substrate
0,415  0,002  Liver X receptor alpha agonist
0,443  0,032  Antineoplastic (melanoma)
0,414  0,006  Antiviral (Influenza A)
0,426  0,019  Antineoplastic (liver cancer)
0,455  0,048  Calcium channel L-type activator
0,411  0,004  Antiinfertility, female
0,448  0,042  Prostate cancer treatment
0,408  0,004  Potassium channel large-conductance Ca-activated activator
0,409  0,004  Gastrin inhibitor
0,422  0,021  Hypolipemic
0,434  0,034  Caspase 3 stimulant
0,412  0,013  Contraceptive
0,399  0,011  Antiacne
0,395  0,008  Interleukin 6 antagonist
0,421  0,034  AR expression inhibitor
0,402  0,016  Sodium/bile acid cotransporter inhibitor
0,425  0,039  Antineoplastic (ovarian cancer)
0,391  0,012  Antiviral (Influenza)
0,409  0,039  CYP2C19 substrate
0,387  0,024  Sigma receptor agonist
0,365  0,004  TRPA1 agonist
0,378  0,019  UGT1A1 substrate
0,390  0,038  Antineoplastic (cervical cancer)
0,394  0,043  Antipsoriatic
0,356  0,006  UGT2B9 substrate
0,396  0,045  Respiratory analeptic
0,348  0,012  UGT2B15 substrate
0,396  0,061  Ulceration
0,347  0,020  Non-steroidal antiinflammatory agent
0,340  0,015  Lipocortins synthesis antagonist
0,391  0,067  Immunosuppressant
0,358  0,042  Cytotoxic
0,372  0,059  Antineoplastic (colorectal cancer)
0,355  0,042  NOS2 expression inhibitor
0,345  0,035  Vascular (periferal) disease treatment
0,318  0,010  Cholesterol synthesis inhibitor
0,361  0,057  ICAM1 expression inhibitor
0,318  0,017  Hair growth stimulant
0,303  0,005  Potassium channel (Ca-activated) activator
0,352  0,055  Apoptosis antagonist
0,354  0,060  Antineoplastic (colon cancer)
0,342  0,048  Antineoplastic (glioma)
0,388  0,098  Cyclophilin D inhibitor
0,388  0,098  Antidiabetic
0,296  0,010  Antifungal enhancer
0,306  0,028  Hepatoprotectant
0,311  0,036  Antihypertriglyceridemic
0,268  0,003  Ornithine decarboxylase inhibitor
0,322  0,062  Analeptic
0,293  0,033  Antihelmintic
0,272  0,013  LDLR expression enhancer
0,307  0,050  Tumour necrosis factor alpha release inhibitor
0,275  0,021  Protein kinase stimulant
0,306  0,056  Chemoprotective
0,314  0,064  Cardioprotectant
0,284  0,039  UDP-glucuronosyltransferase substrate
0,252  0,007  HDL-cholesterol increasing
0,289  0,046  Antiparasitic
0,250  0,010  UGT2B1 substrate
0,239  0,003  Liver X receptor beta agonist
0,314  0,080  Bone diseases treatment
0,236  0,002  Liver X receptor beta antagonist
0,333  0,100  Atherosclerosis treatment
0,297  0,067  Hypoxia-inducible factor 1 alpha inhibitor
0,269  0,038  Muscle relaxant
0,292  0,064  Teratogen
0,231  0,004  5-Alpha-reductase inhibitor
0,234  0,009  Contraceptive female
0,233  0,010  Arachidonic acid antagonist
0,268  0,047  Antiparkinsonian, rigidity relieving
0,300  0,080  Antifungal
0,271  0,052  Antiulcerative
0,234  0,018  UGT2B10 substrate
0,278  0,065  Embryotoxic
0,276  0,062  Hypoglycemic
0,211  0,004  Glutamate release inhibitor
0,229  0,023  Cocaine dependence treatment
0,230  0,024  Anesthetic local
0,281  0,075  Antiosteoporotic
0,245  0,042  Neurotrophic factor enhancer
0,203  0,003  Liver X receptor alpha antagonist
0,219  0,024  Protein-tyrosine phosphatase 1B inhibitor
0,280  0,086  Antineoplastic (osteosarcoma)
0,268  0,075  Antioxidant
0,229  0,037  Protein-tyrosine phosphatase inhibitor
0,260  0,069  Proliferative diseases treatment
0,222  0,035  Antiparkinsonian, tremor relieving
0,203  0,016  Choleretic
0,206  0,019  Endometrios treatment
0,196  0,010  Actinic keratosis treatment
0,278  0,092  CYP2D6 substrate
0,274  0,089  CTGF expression inhibitor
0,218  0,034  VEGF expression inhibitor
0,201  0,021  Retinoprotector
0,234  0,055  Platelet adhesion inhibitor
0,203  0,026  Antihyperlipoproteinemic
0,296  0,119  Antiobesity
0,181  0,004  Liver X receptor agonist
0,259  0,084  Antidiabetic (type 2)
0,179  0,004  Liver X receptor antagonist
0,180  0,007  Antiviral (Coronavirus)
0,180  0,007  Antiviral (SARS coronavirus)
0,204  0,034  Insulin secretagoues
0,180  0,010  Keratolytic
0,245  0,076  Cardiovascular analeptic
0,183  0,017  Pregnane X receptor agonist
0,190  0,025  Farnesoid X receptor antagonist
0,282  0,118  Stroke treatment
0,202  0,046  Antiviral (Herpes)
0,217  0,063  Sedative
0,222  0,069  Antineoplastic enhancer
0,235  0,081  Acute neurologic disorders treatment
0,234  0,081  Antiprotozoal (Leishmania)
0,176  0,024  Nav1.1 sodium channel blocker
0,202  0,050  Antihelmintic (Nematodes)
0,185  0,033  DNA polymerase I inhibitor
0,265  0,115  Antithrombotic
0,243  0,094  Spasmolytic
0,287  0,140  15-Lipoxygenase inhibitor
0,225  0,079  Cardiodepressant
0,189  0,046  Melanin inhibitor
0,146  0,003  Retinoid X alpha receptor agonist
0,170  0,027  SULT1A1 substrate
0,263  0,122  Vasodilator, coronary
0,203  0,062  P-glycoprotein inhibitor
0,213  0,073  Psychostimulant
0,271  0,132  Antineoplastic (non-Hodgkin's lymphoma)
0,189  0,052  Toxic, respiratory center
0,187  0,050  Phospholipase A2 inhibitor
0,214  0,078  Antineoplastic (glioblastoma multiforme)
0,152  0,017  Anabolic
0,163  0,032  Interleukin 1b antagonist
0,152  0,022  Androgen antagonist
0,162  0,033  Growth stimulant
0,130  0,003  Cholesterol ester transfer protein antagonist
0,163  0,038  Cyclooxygenase 3 inhibitor
0,140  0,015  Tocolytic
0,128  0,004  Heme oxygenase stimulant
0,130  0,007  Acetyl-CoA transferase inhibitor
0,211  0,089  Angiogenesis stimulant
0,147  0,025  Hedgehog signaling inhibitor
0,177  0,055  Diuretic
0,169  0,047  Interleukin 1 antagonist
0,124  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,122  0,003  Retinoid X receptor agonist
0,133  0,015  Aromatase inhibitor
0,147  0,029  Sulfotransferase substrate
0,125  0,009  Anticholelithogenic
0,129  0,014  Bile acid receptor antagonist
0,137  0,022  UGT2B11 substrate
0,126  0,011  Glycine receptor agonist
0,129  0,015  3C-Like protease (SARS coronavirus) inhibitor
0,126  0,013  Hyperparathyroidism treatment
0,230  0,117  CYP1A2 substrate
0,177  0,067  Antipruritic
0,240  0,130  Interleukin 2 agonist
0,164  0,060  NOS3 expression enhancer
0,234  0,132  CYP3A4 inhibitor
0,200  0,099  RNA-directed DNA polymerase inhibitor
0,173  0,073  Tumour necrosis factor antagonist
0,107  0,010  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,145  0,049  Antiviral (Hepatitis B)
0,120  0,025  Transcription factor NF kappa B stimulant
0,152  0,059  Adenylate cyclase stimulant
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,130  0,038  Estrogen antagonist
0,169  0,077  Phobic disorders treatment
0,214  0,125  Antiepileptic
0,107  0,019  Cushing's syndrome treatment
0,106  0,020  SULT1A2 substrate
0,094  0,009  Aldosterone antagonist
0,104  0,020  Estrogen-related receptor beta agonist
0,108  0,024  CDC25A inhibitor
0,105  0,024  Estrogen receptor alpha antagonist
0,130  0,050  Alcohol dehydrogenase substrate
0,089  0,010  Potassium channel Kv1.3 blocker
0,146  0,071  Lipid peroxidase inhibitor
0,105  0,032  Contraceptive male
0,180  0,108  Antialcoholic
0,133  0,061  Vanilloid 1 agonist
0,162  0,091  Diabetic nephropathy treatment
0,113  0,042  Estrogen receptor beta antagonist
0,117  0,047  Anticataract
0,073  0,005  Alpha 1L adrenoreceptor agonist
0,124  0,056  Microtubule formation inhibitor
0,162  0,095  Wound healing agent
0,071  0,004  Retinoid X receptor antagonist
0,137  0,070  Antieczematic
0,193  0,127  Interleukin agonist
0,158  0,093  Carcinogenic
0,071  0,006  5-Alpha-reductase 1 inhibitor
0,069  0,004  Retinoid X gamma receptor agonist
0,140  0,076  Skeletal muscle relaxant
0,076  0,013  Acetyl-CoA transferase 2 inhibitor
0,097  0,035  Glycine receptor antagonist
0,070  0,007  Farnesoid X receptor agonist
0,151  0,092  Male reproductive disfunction treatment
0,075  0,017  Lipocortins synthesis agonist
0,062  0,004  Retinoid X alpha receptor antagonist
0,080  0,023  Estrogen agonist
0,213  0,157  Antihypertensive
0,154  0,098  Phospholipase C inhibitor
0,120  0,064  Antitussive
0,062  0,006  5-Alpha-reductase 2 inhibitor
0,073  0,018  Postcoital contraceptive
0,075  0,020  Calcium channel P-type blocker
0,228  0,173  Histamine release inhibitor
0,064  0,010  Glucocorticoid antagonist
0,066  0,013  Progesterone antagonist
0,063  0,010  RNA-directed RNA polymerase stimulant
0,080  0,028  CDC25B inhibitor
0,177  0,125  Vasodilator
0,234  0,183  CYP2C9 inhibitor
0,060  0,009  Acetyl-CoA transferase 1 inhibitor
0,087  0,037  Narcotic antagonist
0,078  0,028  Uterine relaxant
0,066  0,016  Mineralocorticoid receptor antagonist
0,058  0,010  Retinoic acid alpha receptor agonist
0,125  0,078  Nav1.2 sodium channel blocker
0,060  0,014  Geranyltranstransferase inhibitor
0,074  0,028  Androgen agonist
0,083  0,037  Calcium channel L-type blocker
0,061  0,016  Cholesterol esterase inhibitor
0,148  0,104  ATPase inhibitor
0,127  0,084  Psychosexual dysfunction treatment
0,089  0,047  Opioid kappa receptor antagonist
0,044  0,003  Retinoid X beta receptor antagonist
0,093  0,053  Calcium antagonist
0,045  0,005  Retinoid X beta receptor agonist
0,044  0,004  Retinoid X gamma receptor antagonist
0,055  0,016  Parathyroid hormone antagonist
0,104  0,065  AMP-activated protein kinase stimulant
0,057  0,019  Opioid kappa receptor agonist
0,103  0,065  Toll-Like receptor 4 antagonist
0,093  0,057  Potassium channel activator
0,040  0,004  Retinoic acid alpha receptor antagonist
0,110  0,075  Menstruation disorders treatment
0,039  0,004  Retinoic acid receptor antagonist
0,086  0,052  Inducible nitric-oxide synthase inhibitor
0,120  0,087  Calcium channel blocker
0,067  0,034  Transcription factor AP-1 inhibitor
0,063  0,031  Postmenopausal disorders treatment
0,120  0,088  Liver cirrhosis treatment
0,044  0,014  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,038  0,007  Retinoic acid receptor agonist
0,066  0,036  Antimycoplasmal
0,034  0,005  Retinoic acid gamma receptor agonist
0,148  0,119  Antiviral (Hepatitis)
0,183  0,155  Renal disease treatment
0,108  0,080  Autism spectrum disorders treatment
0,034  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,057  0,033  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,064  0,041  Nitric oxide donor
0,123  0,101  CC chemokine 6 receptor antagonist
0,235  0,214  Antiarthritic
0,049  0,028  Adenylate cyclase 1 inhibitor
0,103  0,082  Adenylate cyclase inhibitor
0,026  0,007  Retinoic acid beta receptor agonist
0,057  0,039  Pregnane X receptor antagonist
0,027  0,009  Vitamin D receptor antagonist
0,065  0,048  Hypercalcemia treatment
0,036  0,019  Melatonin receptor 1A agonist
0,034  0,018  ATP citrate lysase inhibitor
0,020  0,004  Retinoic acid beta receptor antagonist
0,036  0,021  HMG CoA reductase inhibitor
0,085  0,070  Paget's disease treatment
0,019  0,004  Retinoic acid receptor gamma antagonist
0,089  0,075  Lanosterol 14 alpha demethylase inhibitor
0,067  0,053  SULT2A1 substrate
0,078  0,066  Antiprotozoal activity enhancer
0,086  0,075  Butyrylcholinesterase inhibitor
0,110  0,099  Antiviral (Papilloma)
0,037  0,027  Glucose-6-phosphate dehydrogenase inhibitor
0,028  0,019  Hedgehog signaling activator
0,157  0,148  Immunostimulant
0,023  0,014  Estrone sulfatase inhibitor
0,022  0,014  Corticosteroid-like
0,076  0,070  Antineoplastic alkaloid
0,145  0,140  Insulin sensitizer
0,087  0,082  Skin irritative effect
0,056  0,051  Potassium channel intermediate-conductance Ca-activated blocker
0,072  0,067  Chymotrypsin inhibitor
0,030  0,026  Estrogen receptor alpha agonist
0,097  0,094  Acetylcholine release stimulant
0,082  0,078  Prolactin inhibitor
0,157  0,155  Myocardial infarction treatment
0,047  0,045  Anesthetic inhalation
0,016  0,014  Progesterone agonist
0,116  0,115  Urinary incontinence treatment
0,163  0,162  Age-related macular degeneration treatment
0,150  0,149  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,133  0,132  Interleukin antagonist
0,177  0,176  12-Lipoxygenase inhibitor
0,125  0,125  Muscular dystrophy treatment

